Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (41-50 of 352) with videos related to

Pageof 36
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 30, 2021
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccinesValentin Al Jalali, Sabine Scherzer, Markus Zeitlinger
The AAPS Journal|January 2, 2009
Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killingJürgen Beer, Claudia Christina Wagner, Markus Zeitlinger
International Journal of Antimicrobial Agents|February 25, 2026
In reply to the Letter to Editor regarding 'Pharmacokinetics of Ampicillin, Sulbactam, and Combined Ampicillin/Sulbactam in Subcutis, Muscle, and Plasma: A Microdialysis Trial in Healthy Volunteers'Anselm Jorda, Markus Zeitlinger, Valentin Al Jalali
The Journal of Antimicrobial Chemotherapy|November 19, 2024
Comment on: Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South AsiaMarlene Prager, Valentin Al Jalali, Markus Zeitlinger
Clinical Pharmacokinetics|January 10, 2025
Clinical Pharmacokinetics of Antitubercular Drugs in the Overweight and Obese Population: Implications for Dosage AdjustmentsMarlene Prager, Valentin Al Jalali, Markus Zeitlinger
European Journal of Drug Metabolism and Pharmacokinetics|April 23, 2025
Host Biomarkers and Antibiotic Tissue Penetration in Sepsis: Insights from MoxifloxacinMaria Sanz-Codina, Hartmuth Nowak, Markus Zeitlinger
Pharmacology|February 17, 2016
Understanding the Activity of Antibiotics in Cerebrospinal Fluid in vitroPeter Matzneller, Angela Burian, Markus Zeitlinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2024
Revisiting the Evidence: Corticosteroid Efficacy in Patients With Moderate and Severe Community-Acquired PneumoniaFelix Bergmann, Christine Radtke, Markus Zeitlinger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 16, 2021
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?Matthias Karer, Karin Stiasny, Markus Zeitlinger, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjectsSongmao Zheng, Peter Matzneller, Markus Zeitlinger, et al.
Pageof 36

Showing results (41-50 of 352) with videos related to

Sort By:
Pageof 36
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 30, 2021
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccinesValentin Al Jalali, Sabine Scherzer, Markus Zeitlinger
The AAPS Journal|January 2, 2009
Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killingJürgen Beer, Claudia Christina Wagner, Markus Zeitlinger
International Journal of Antimicrobial Agents|February 25, 2026
In reply to the Letter to Editor regarding 'Pharmacokinetics of Ampicillin, Sulbactam, and Combined Ampicillin/Sulbactam in Subcutis, Muscle, and Plasma: A Microdialysis Trial in Healthy Volunteers'Anselm Jorda, Markus Zeitlinger, Valentin Al Jalali
The Journal of Antimicrobial Chemotherapy|November 19, 2024
Comment on: Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South AsiaMarlene Prager, Valentin Al Jalali, Markus Zeitlinger
Clinical Pharmacokinetics|January 10, 2025
Clinical Pharmacokinetics of Antitubercular Drugs in the Overweight and Obese Population: Implications for Dosage AdjustmentsMarlene Prager, Valentin Al Jalali, Markus Zeitlinger
European Journal of Drug Metabolism and Pharmacokinetics|April 23, 2025
Host Biomarkers and Antibiotic Tissue Penetration in Sepsis: Insights from MoxifloxacinMaria Sanz-Codina, Hartmuth Nowak, Markus Zeitlinger
Pharmacology|February 17, 2016
Understanding the Activity of Antibiotics in Cerebrospinal Fluid in vitroPeter Matzneller, Angela Burian, Markus Zeitlinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2024
Revisiting the Evidence: Corticosteroid Efficacy in Patients With Moderate and Severe Community-Acquired PneumoniaFelix Bergmann, Christine Radtke, Markus Zeitlinger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 16, 2021
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?Matthias Karer, Karin Stiasny, Markus Zeitlinger, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjectsSongmao Zheng, Peter Matzneller, Markus Zeitlinger, et al.
Pageof 36